-
1
-
-
0034517377
-
Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract
-
Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 2000;12:181-185.
-
(2000)
Curr Opin Oncol
, vol.12
, pp. 181-185
-
-
Schuchter, L.M.1
Green, R.2
Fraker, D.3
-
3
-
-
0031138367
-
Primary anorectal melanoma, apropos of 19 cases
-
Dube P, Elias D, Bonvalot S, et al. Primary anorectal melanoma, apropos of 19 cases [in French]. J Chir. 1997;134:3-8.
-
(1997)
J Chir
, vol.134
, pp. 3-8
-
-
Dube, P.1
Elias, D.2
Bonvalot, S.3
-
4
-
-
0032843504
-
Changing epidemiology of anorectal melanoma
-
Cagir B, Whiteford MH, Topham A, et al. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42:1203-1208.
-
(1999)
Dis Colon Rectum
, vol.42
, pp. 1203-1208
-
-
Cagir, B.1
Whiteford, M.H.2
Topham, A.3
-
6
-
-
0002230506
-
-
St. Louis, Mo: Quality Medical Publishing
-
Balch C, Houghton A, Sober A, et al, eds. Mucosal Melanomas in Cutaneous Melanoma. St. Louis, Mo: Quality Medical Publishing; 1998:195-220.
-
(1998)
Mucosal Melanomas in Cutaneous Melanoma
, pp. 195-220
-
-
Balch, C.1
Houghton, A.2
Sober, A.3
-
7
-
-
0025136799
-
Patterns of failure in anorectal melanoma, a guide to surgical therapy
-
Ross M, Pezzi C, Pezzi T, et al. Patterns of failure in anorectal melanoma, a guide to surgical therapy. Arch Surg (United States). 1990;125:313-316.
-
(1990)
Arch Surg (United States)
, vol.125
, pp. 313-316
-
-
Ross, M.1
Pezzi, C.2
Pezzi, T.3
-
10
-
-
0032531854
-
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade
-
The American College of Surgeons Commission on Cancer and the American Cancer Society
-
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-1678.
-
(1998)
Cancer
, vol.83
, pp. 1664-1678
-
-
Chang, A.E.1
Karnell, L.H.2
Menck, H.R.3
-
12
-
-
0025058539
-
Anorectal melanoma: Clinical characteristics and results of surgical management in twenty-four patients
-
Slingluff CL, Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery. 1990;107:1-9.
-
(1990)
Surgery
, vol.107
, pp. 1-9
-
-
Slingluff, C.L.1
Vollmer, R.T.2
Seigler, H.F.3
-
13
-
-
0035460233
-
Anal melanoma: An aggressive malignancy masquerading as hemorrhoids
-
Felz MW, Winburn GB, Kallab AM, et al. Anal melanoma: an aggressive malignancy masquerading as hemorrhoids. South Med J. 2001;94:880-885.
-
(2001)
South Med J
, vol.94
, pp. 880-885
-
-
Felz, M.W.1
Winburn, G.B.2
Kallab, A.M.3
-
15
-
-
0031411613
-
Mucosal, genital, and unusual clinical variants of melanoma
-
Rogers RS III. Gibson LE. Mucosal, genital, and unusual clinical variants of melanoma. Mayo Clin Proc. 1997;72:362-366.
-
(1997)
Mayo Clin Proc
, vol.72
, pp. 362-366
-
-
Rogers III, R.S.1
Gibson, L.E.2
-
16
-
-
0034849915
-
Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma
-
Dubois RW, Swetter SM, Atkins M, et al. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Arch Dermatol. 2001;137:1217-1224.
-
(2001)
Arch Dermatol
, vol.137
, pp. 1217-1224
-
-
Dubois, R.W.1
Swetter, S.M.2
Atkins, M.3
-
17
-
-
0030030347
-
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
-
Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.
-
(1996)
J Clin Oncol
, vol.14
, pp. 7-17
-
-
Kirkwood, J.M.1
Strawderman, M.H.2
Ernstoff, M.S.3
-
18
-
-
0034088027
-
High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190
-
Kirkwood JM, Ibrahim JG, Sondak VK, et el. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol. 2000;18:2444-2458.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2444-2458
-
-
Kirkwood, J.M.1
Ibrahim, J.G.2
Sondak, V.K.3
-
19
-
-
0035339880
-
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/qs-21 vaccine in patients with resected stage IIb-III melanoma: Results of Intergroup Trial E1694/S9512/C509801
-
Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/qs-21 vaccine in patients with resected stage IIb-III melanoma: results of Intergroup Trial E1694/S9512/C509801. J Clin Oncol. 2000;19:2370-2380.
-
(2000)
J Clin Oncol
, vol.19
, pp. 2370-2380
-
-
Kirkwood, J.M.1
Ibrahim, J.G.2
Sosman, J.A.3
-
20
-
-
0028942087
-
Anorectal melanoma, a 64-year experience at Memorial Sloan-Kettering Cancer Center
-
Brady MS, Kavolius JP, Quan SH. Anorectal melanoma, a 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995;38:146-151.
-
(1995)
Dis Colon Rectum
, vol.38
, pp. 146-151
-
-
Brady, M.S.1
Kavolius, J.P.2
Quan, S.H.3
|